Singular Health Group Ltd (ASX:SHG)
Australia
· Delayed Price · Currency is AUD 0.255
+0.010 (4.08%)
At close: Mar 6, 2026
Singular Health Group Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 |
| Operating Revenue | 0.96 | 0.56 | 0.93 | 0.44 | 0.42 | 0.46 | Upgrade
|
| Other Revenue | - | - | - | - | 0 | 0 | Upgrade
|
| Revenue | 0.96 | 0.56 | 0.93 | 0.44 | 0.42 | 0.46 | Upgrade
|
| Revenue Growth (YoY) | 9.52% | -40.30% | 111.17% | 5.79% | -8.79% | 260.66% | Upgrade
|
| Cost of Revenue | 0.87 | 0.64 | 0.42 | 0.59 | 0.6 | 0.19 | Upgrade
|
| Gross Profit | 0.09 | -0.09 | 0.52 | -0.15 | -0.18 | 0.27 | Upgrade
|
| Selling, General & Admin | 4.16 | 2.85 | 2.19 | 2.67 | 2.79 | 2.45 | Upgrade
|
| Other Operating Expenses | -0.03 | 0.07 | 0.03 | 0.01 | 0.03 | -0.04 | Upgrade
|
| Operating Expenses | 7.89 | 6.31 | 3.61 | 4.22 | 5.74 | 3.26 | Upgrade
|
| Operating Income | -7.8 | -6.4 | -3.09 | -4.37 | -5.92 | -2.99 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.1 | -0.43 | -0.01 | -1.46 | Upgrade
|
| Interest & Investment Income | 0.38 | 0.14 | 0.31 | 0 | 0.01 | 0 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.01 | -0.06 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -7.43 | -6.26 | -2.87 | -4.81 | -5.99 | -4.46 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0 | -0.16 | - | - | Upgrade
|
| Pretax Income | -7.43 | -6.26 | -2.88 | -4.97 | -5.99 | -4.46 | Upgrade
|
| Earnings From Continuing Operations | -7.43 | -6.26 | -2.88 | -4.97 | -5.99 | -4.46 | Upgrade
|
| Earnings From Discontinued Operations | 0 | -0.11 | -2.05 | -0.42 | - | - | Upgrade
|
| Net Income | -7.43 | -6.38 | -4.92 | -5.39 | -5.99 | -4.46 | Upgrade
|
| Net Income to Common | -7.43 | -6.38 | -4.92 | -5.39 | -5.99 | -4.46 | Upgrade
|
| Shares Outstanding (Basic) | 317 | 237 | 160 | 110 | 103 | 74 | Upgrade
|
| Shares Outstanding (Diluted) | 317 | 237 | 160 | 110 | 103 | 74 | Upgrade
|
| Shares Change (YoY) | 92.24% | 48.02% | 45.63% | 6.98% | 38.82% | 396.41% | Upgrade
|
| EPS (Basic) | -0.02 | -0.03 | -0.03 | -0.05 | -0.06 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.03 | -0.03 | -0.05 | -0.06 | -0.06 | Upgrade
|
| Free Cash Flow | -4.38 | -2.37 | -2.51 | -2.43 | -2.92 | -1.96 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.03 | Upgrade
|
| Gross Margin | 9.44% | -15.46% | 55.28% | -32.87% | -43.02% | 58.60% | Upgrade
|
| Operating Margin | -811.31% | -1147.05% | -330.80% | -987.82% | -1415.80% | -652.20% | Upgrade
|
| Profit Margin | -772.78% | -1143.49% | -527.23% | -1218.59% | -1431.58% | -972.05% | Upgrade
|
| Free Cash Flow Margin | -455.13% | -425.12% | -269.13% | -548.25% | -697.75% | -427.04% | Upgrade
|
| EBITDA | -7.7 | -6.27 | -2.58 | -4.05 | -5.72 | -2.9 | Upgrade
|
| EBITDA Margin | - | - | -276.50% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.1 | 0.13 | 0.51 | 0.32 | 0.2 | 0.09 | Upgrade
|
| EBIT | -7.8 | -6.4 | -3.09 | -4.37 | -5.92 | -2.99 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.